The role of phosphatidylinositol 3′-kinase and its downstream signals in erbB-2-mediated transformation

Molecular Cancer Research

Volumn 1, Issue 7, 2003, Pages 551-560

  Woods Ignatoski, Kathleen M ^a   Livant, Donna L ^a   Markwart, Sonja ^a   Grewal, Navdeep K ^a   Ethier, Stephen P ^a,b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; 4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; PROTEIN KINASE C; SYNAPTOPHYSIN;

ARTICLE; BREAST EPITHELIUM; CELL ANCHORAGE; CELL INVASION; CELL MOTILITY; CONTROLLED STUDY; ENZYME ACTIVATION; GENE ACTIVATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; ONCOGENE NEU; PHENOTYPE; PRIORITY JOURNAL;

1-PHOSPHATIDYLINOSITOL 3-KINASE; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; CHEMOTAXIS; ENZYME INHIBITORS; HUMANS; IMIDAZOLES; PHAGOCYTOSIS; PYRIDINES; RECEPTOR, ERBB-2; SIGNAL TRANSDUCTION; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0037598679     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Berger, M. S., Locher, G. W., Saurer, S., Gullick, W. J., Waterfield, M. D., Groner, B., and Hynes, N. E. Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading. Cancer Res., 48: 1238-1243, 1988.
2. Guerin, M., Gabillot, M., Mathieu, M. C., Travagli, J. P., Spielmann, N. A., and Riou, G. Structure and expression of c-erbB-2 and EGF receptor genes inflammatory and non-inflammatory breast cancer: prognostic significance. Int. J. Cancer, 43: 201-208, 1989.
3. Ram, T. G., Dilts, C. A., Dziubinski, M. L., Pierce, L. J., and Ethier, S. P. Insulin-like growth factor and epidermal growth factor independence in human mammary carcinoma cells with c-erbB-2 gene amplification and progressively elevated levels of tyrosine phosphorylated erbB-2. Mol. Carcinog., 15: 227-238, 1996.
4. Woods Ignatoski, K. M., LaPointe, A. J., Radany, E. H., and Ethier, S. P. ErbB-2 overexpression in human mammary epithelial cells confers growth factor independence. Endocrinology, 140: 3615-3622, 1999.
5. Woods Ignatoski, K. M., Maehama, T., Markwart, S. M., Dixon, J. E., Livant, D. L., and Ethier, S. P. ERBB-2 overexpression confers PI 3′-kinase-dependent invasion capacity on human mammary epithelial cells. Br. J. Cancer, 82: 666-674, 2000.
6. Gullick, W. J. and Srinivasan, R. The type 1 growth factor receptor family: new ligands and receptors and their role in breast cancer. Breast Cancer Res. Treat., 52: 43-53, 1998.
7. Goldman, R., Benlevy, R., Peles, E., and Yarden, Y. Heterodimerization of the erbB-1 and erbB-2 receptors in human breast carcinoma cells - a mechanism for receptor transregulation. Biochemistry, 29: 11024-11028, 1990.
8. Graus-Porta, D., Beerli, R. R., Daly, J. M., and Hynes, N. E. ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling. EMBO J., 16: 1647-1655, 1997.
9. Olayioye, M. A., Graus-Porta, D., Beerli, R. R., Rohrer, J., Gay, B., and Hynes, N. E. ErbB-1 and ErbB-2 acquire distinct signaling properties dependent upon their dimerization partner. Mol. Cell. Biol., 5042-5051, 1998.
10. Ram, T. G. and Ethier, S. P. Phosphatidylinositol 3-kinase recruitment by p185(erbB-2) and erbB-3 is potently induced by neu differentiation factor/heregulin during mitogenesis and is constitutively elevated in growth factor-independent breast carcinoma cells with c-erbB-2 gene amplification. Cell Growth & Differ., 7. 551-561, 1996.
11. Fruman, D. A., Meyers, R. E., and Cantley, L. C. Phosphoinositide kinases. Annu. Rev. Biochem., 67: 481-507, 1998.
12. Wymann, M. P. and Pirola, L. Structure and function of phosphoinositide 3-kinases. Biochim. Biophys. Acta, 1436: 127-150, 1998.
13. Reedijk, M., Liu, X., van der Geer, P., Letwin, K., Waterfield, M. D., Hunter, T., and Pawson, T. Tyr721 regulates specific binding of the CSF-1 receptor kinase insert to PI Y-kinase SH2 domains: a model for SH2-mediated receptor-target interactions. EMBO J., 11: 1365-1372, 1992.
14. Auger, K. R., Serunian, L. A., Soltoff, S. P., Libby, P., and Cantley, L. C. PDGF-dependent tyrosine phosphorylation stimulates production of novel polyphosphoinositides in intact cells. Cell, 57: 167-175, 1989.
15. Burgering, B. M. and Coffer, P. J. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature, 376: 599-602, 1995.
16. Cheatham, B., Vlahos, C. J., Cheatham, L., Wang, L., Blenis, J., and Kahn, C. R. Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation. Mol. Cell. Biol., 14: 4902-4911, 1994.
17. Datta, K., Bellacosa, A., Chan, T. O., and Tsichlis, P. N. Akt is a direct target of the phosphatidylinositol 3-kinase. J. Biol. Chem., 271: 30835-30839, 1996.
18. Insall, R. and Weiner, O. PIP3, PIP2, and cell movement - similar messages, different meanings? Dev. Cell, 1: 743-747, 2001.
19. Cockcroft, S. Mammalian phosphatidylinositol transfer proteins: emerging roles in signal transduction and vesicular traffic. Chem. Phys. Lipids, 98: 23-33, 1999.
20. Kolanus, W. and Seed, B. Integrins and inside-out signal transduction: converging signals from PKC and PIP3. Curr. Opin. Cell Biol., 9: 725-731, 1997.
21. Maehama, T. and Dixon, J. E. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J. Biol. Chem., 273: 13375-13378, 1998.
22. Rani, M. J., Coxon, P. Y., Powell, D. W., Webster, R., Klein, J. B., Pierce, W., Ping, P., and McLeish, K. R. p38 Kinase-dependent MAPKAPK-2 activation functions as 3-phosphoinositide-dependent kinase-2 for Akt in human neutrophils. J. Biol. Chem., 276: 3517-3523, 2001.
23. Tabakoff, B., Nelson, E., Yoshimura, M., Hellevuo, K., and Hoffman, P. Phosphorylation cascades control the actions of ethanol on cell cAMP signalling. J. Biomed. Sci., 8: 44-51, 2001.
24. Davies, S. P., Reddy, H., Caivano, M., and Cohen, P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J., 351: 95-105, 2000.
25. Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., and McGuire, W. L. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science, 235: 177-182, 1987.
26. Kennedy, S. G., Wagner, A. J., Conzen, S. D., Jordan, J., Bellacosa, A., Tsichlis, P. N., and Hay, N. The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. Genes Dev., 11: 701-713, 1997.
27. Datta, S. R., Dudek, H., Tao, X., Masters, S., Fu, H., Gotoh, Y., and Greenberg, M. E. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell, 91: 231-241, 1997.
28. Matsuzaki, H., Tamatani, M., Mitsuda, N., Namikawa, K., Kiyama, H., Miyake, S., and Tohyama, M. Activation of Akt kinase inhibits apoptosis and changes in Bcl-2 and Bax expression induced by nitric oxide in primary hippocampalneurons. J. Neurochem., 73: 2037-2046, 1999.
29. del Peso, L., Gonzalez-Garcia, M., Page, C., Herrera, R., and Nunez, G. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science, 278: 687-689, 1997.
30. Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J., and Greenberg, M. E. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell, 96: 857-868, 1999.
31. Kim, D., Kim, S., Koh, H., Yoon, S. O., Chung, A. S., Cho, K. S., and Chung, J. Akt/PKB promotes cancer cell invasion via increased motility and metalloproteinase production. FASEB J., 15: 1953-1962, 2001.
32. Park, B., Zeng, X., and Glazer, R. AKT1 induces extracellular matrix invasion and matrix metalloproteinase-2 activity in mouse mammary epithelial cells. Cancer Res., 61: 7647-7653, 2001.
33. Tanno, S., Tanno, S., Mitsuuchi, Y., Altomare, D., Xiao, G., and Testa, J. AKT activation up-regulates insulin-like growth factor 1 receptor expression and promotes invasiveness of human pancreatic cells. Cancer Res., 61: 589-593, 2001.
34. Nieman, M. T., Prudoff, R. S., Johnson, K. R., and Wheelock, M. J. N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression. J. Cell Biol., 147: 631-644, 1999.
35. Livant, D. L., Linn, S., Markwart, S., and Shuster, J. Invasion of selectively permeable sea urchin embryo basement membranes by metastatic tumor cells, but not by their normal counterparts. Cancer Res., 55: 5085-5093, 1995.
36. Maffucci, T. and Falasca, M. Specificity in pleckstrin homology (PH) domain membrane targeting: a role for a phosphoinositide-protein co-operative mechanism. FEBS Lett., 506: 173-179, 2001.
37. Lemmon, M. and Ferguson, K. Signal-dependent membrane targeting by pleckstrin homology (PH) domains. Biochem. J., 350: 1-18, 2000.
38. Lam, K., Zhang, L., Yamada, K. M., and Lafrenie, R. M. Adhesion of epithelial cells to fibronectin or collagen 1 induces alterations in gene expression via a protein kinase C-dependent mechanism. J. Cell. Physiol., 189: 79-90, 2001.
39. Mills, G., Lu, Y., Fang, X., Wang, H., Eder, A., Mao, M., Swaby, R., Cheng, K., Stokoe, D., Siminovich, K., Jaffe, R., and Gray, J. The role of PTEN and the phosphatidylinositol 3-kinase pathway in breast and ovarian tumorigenesis, prognosis, and therapy. Semin. Oncol., 28: 125-141, 2001.
40. Bennett, I., Gattas, M., and Teh, B. The genetic basis of breast cancer and its clinical implications. Aust. N. Z. J. Surg., 69: 95-105, 1999.
41. Harris, K. F., Christensen, J. B., Radany, E. H., and Imperiale, M. J. Novel mechanisms of E2F induction by BK virus large Tantigen: requirement of both the pRb binding and J domains. Mol. Cell. Biol., 18: 1746-1756, 1998.
42. Woods Ignatoski, K. and Ethier, S. P. Constitutive activation of pp 125fak in eleven newly isolated breast cancer cell lines. Breast Cancer Res. Treat., 54: 173-182, 1999.
43. Lotan, R., Amos, B., Watanabe, H., and Raz, A. Suppression of melanoma cell motility factor expression by retinoic acid. Cancer Res., 52: 4878-4884, 1992.